Medical University of South Carolina: Prostatic Neoplasms trials

The registry lists 18 Prostatic Neoplasms studies with Medical University of South Carolina as lead sponsor. 2 are open to participants now and 8 have results posted.

Phase 1 6Phase 2 11No phase 3(a study in two phases counts in both)

Studies

Open to participants first, then studies with results posted, then the rest; newest registration first within each.

• Hypofractionated Radiotherapy With a Focal Microboost for High-Risk and Locally Advanced Prostate CancerRecruitingNCT07325721Phase 2
• T-reg Function Changes: a Novel Immune Regulatory Effect Underlying Benefit of Statin Use on Lethal Prostate CancerRecruitingNCT05586360Phase 2
• Vitamin D Supplementation in RNA-seq Profiles of Single-core Prostate Samples, Among VeteransCompletedNCT04621500Phase 2Results posted
• Addition of Opaganib to Androgen Antagonists in Patients With mCRPCCompletedNCT04207255Phase 2Results posted
• Study of Chitosan for Pharmacologic Manipulation of AGE Levels in Prostate Cancer PatientsTerminatedNCT03712371Phase 1/2Results posted
• Study of Pharmacologic Manipulation of AGE (Advanced Glycation Endproducts) Levels in Prostate Cancer Patients Receiving Androgen Deprivation TherapyTerminatedNCT02946996Phase 2Results posted
• Adjuvant PROSTVAC-V/F in Subjects at High Risk for Relapse After Radical ProstatectomyTerminatedNCT02772562Phase 2Results posted
• Vitamin D and Prostate Cancer: A Clinical Study Enrolling Subjects Undergoing ProstatectomyCompletedNCT02726113Phase 2Results posted
• Ph Ib/IIa Study of Cabazitaxel Plus Bavituximab in Castration-resistant Prostate CancerTerminatedNCT01335204Phase 1/2Results posted
• Bortezomib With or Without Hormone Therapy in Treating Patients With Relapsed Prostate CancerTerminatedNCT00103376Phase 2Results posted
• Stereotactic Ablative Radiation Therapy for Prostate CancerActive, not recruitingNCT05668351Not applicable
• Clonal Emergence and Regression During Radium-223 Therapy for Metastatic Prostate CancerCompletedNCT03677076
• Study of Metformin Plus Oligomeric Procyanidin Complex for Pharmacologic Manipulation of AGE (Advanced Glycation Endproducts) Levels in Prostate Cancer PatientsWithdrawnNCT03465345Phase 1
• Evaluating Race Specific AGE Accumulation As a Behavioral Biomarker Prostate Cancer SurvivorsWithdrawnNCT03459755Not applicable
• Docetaxel and Lycopene in Metastatic Prostate CancerCompletedNCT01949519Phase 1
• Vitamin D3 Supplementation in Participants Diagnosed With Early-Stage Prostate Cancer Who Decide to Undergo Active Surveillance Treatment Regimen.CompletedNCT01045109Phase 2
• Docetaxel, Radiation Therapy, and Hormone Therapy in Treating Patients With Locally Advanced Prostate CancerCompletedNCT00099086Phase 1
• Epirubicin and Docetaxel in Treating Patients With Metastatic Prostate CancerTerminatedNCT00096304Phase 1